{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:33:08Z","timestamp":1787841188021,"version":"build-2784847793"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Current biomarkers of epithelial ovarian cancer (EOC) lack the required sensitivity and specificity for early detection. MicroRNAs (miRNAs) are implicated in cancer progression, and their serum expression could serve as a non-invasive diagnostic tool. This study focuses on evaluating the expression of serum miR-200a, miR-200b, and miR-200c and their association with clinico-pathological characteristics in EOC patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>Ninety-eight EOC patients and 96 age-matched healthy women participated. RNA was extracted from serum, and reverse transcription followed by quantitative real-time polymerase chain reaction (qPCR) assessed miRNA (miR) expression. Correlations with clinico-pathological parameters, including FIGO staging and tumor, node, and metastasis (TNM) grading, were explored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Serum levels of miR-200a, miR-200b, and miR-200c were significantly higher in EOC compared to controls (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.01). When correlated with clinico-pathological parameters, miR-200c positively correlated with cancer severity (FIGO staging and TNM grading). In contrast, miR-200a and miR-200b showed no significant associations with clinical severity. Receiver operating characteristic curve analysis demonstrated miR-200a_Ct as the most promising parameter (area under the curve [AUC] = 0.997,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001), with high sensitivity (100%) and specificity (99%) at a cut-off value of &gt;19.50.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The study reveals the overexpression of miR-200a, miR-200b, and miR-200c in EOC patients. MiR-200a and miR-200b expression was correlating with early stage, while miR-200c emerged as a prognostic marker, correlating with cancer severity. This suggests regulatory role; however, further investigation into epithelial-to-mesenchymal transition-related factors is warranted to have a deeper understanding of the differential expression of miRNAs. The study underscores the diagnostic potential of serum miRNAs in EOC and the need for a reliable early detection method.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_356_25","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T13:06:43Z","timestamp":1774876003000},"page":"65-70","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Regulatory effects of miRNA in epithelial ovarian cancer patients: A case\u2013control study from Eastern India"],"prefix":"10.4103","volume":"22","author":[{"given":"Suchitra","family":"Kumari","sequence":"first","affiliation":[{"name":"Department of Biochemistry, All India Institute of Medical Sciences, Bhubaneswar, Sijua, Patrapada, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramadaas","family":"Balamurugan","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, All India Institute of Medical Sciences, Bhubaneswar, Sijua, Patrapada, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saroj K. D.","family":"Majumdar","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, All India Institute of Medical Sciences, Bhubaneswar, Sijua, Patrapada, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilip K.","family":"Muduly","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, All India Institute of Medical Sciences, Bhubaneswar, Sijua, Patrapada, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,3,30]]},"reference":[{"key":"R1-20260331","first-page":"55","article-title":"[Diagnosis of benign ovarian lesions using imaging techniques","volume":"38","author":"Walczewska","year":"2015","journal-title":"Pol Merkur Lekarski"},{"key":"R2-20260331","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.4103\/0366-6999.171459","article-title":"Research progress of microRNA in early detection of ovarian cancer","volume":"128","author":"Wang","year":"2015","journal-title":"Chin Med J (Engl)"},{"key":"R3-20260331","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.cyto.2015.01.035","article-title":"Plasma immune analytes in patients with epithelial ovarian cancer","volume":"73","author":"Block","year":"2015","journal-title":"Cytokine"},{"key":"R4-20260331","first-page":"1099","article-title":"Correlation between CA125 levels after sixth cycle of chemotherapy and clinical outcome in advanced ovarian carcinoma","volume":"35","author":"Gadducci","year":"2015","journal-title":"Anticancer Res"},{"key":"R5-20260331","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1158\/0008-5472.CAN-07-2488","article-title":"MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN","volume":"68","author":"Yang","year":"2008","journal-title":"Cancer Research"},{"key":"R6-20260331","first-page":"328","article-title":"MicroRNA: A new and promising potential biomarker for diagnosis and prognosis of ovarian cancer","volume":"12","author":"Pal","year":"2015","journal-title":"Cancer Biol Med"},{"key":"R7-20260331","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1177\/0300060513487652","article-title":"Serum microRNA-92 expression in patients with ovarian epithelial carcinoma","volume":"41","author":"Guo","year":"2013","journal-title":"J Int Med Res"},{"key":"R8-20260331","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/IGC.0b013e31828c166d","article-title":"Detection of microRNA as novel biomarkers of epithelial ovarian cancer from the serum of ovarian cancer patient","volume":"23","author":"Chung","year":"2013","journal-title":"Int J Gynecol Cancer"},{"key":"R9-20260331","doi-asserted-by":"crossref","first-page":"8699","DOI":"10.1158\/0008-5472.CAN-07-1936","article-title":"MicroRNA signatures in human ovarian cancer","volume":"67","author":"Iorio","year":"2007","journal-title":"Clin Cancer Res"},{"key":"R10-20260331","doi-asserted-by":"crossref","first-page":"e77853","DOI":"10.1371\/journal.pone.0077853","article-title":"Plasma miRNAs as diagnostic and prognostic biomarkers for ovarian cancer","volume":"8","author":"Zheng","year":"2013","journal-title":"PLoS One"},{"key":"R11-20260331","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1136\/gutjnl-2011-301846","article-title":"MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis","volume":"62","author":"Hur","year":"2013","journal-title":"Gut"},{"key":"R12-20260331","first-page":"3404059","article-title":"miR-200b\/200a\/429 cluster stimulates ovarian cancer development by targeting ING5","author":"Guan","year":"2020","journal-title":"J Oncol 2020"},{"key":"R13-20260331","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12964-014-0062-x","article-title":"MiR200-upregulated vasohibin 2 promotes the malignant transformation of tumors by inducing epithelial-mesenchymal transition in hepatocellular carcinoma","volume":"12","author":"Xue","year":"2014","journal-title":"Cell Commun Signal"},{"key":"R14-20260331","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.4161\/cc.7.20.6851","article-title":"MicroRNAs as regulators of epithelial-mesenchymal transition","volume":"7","author":"Gregory","year":"2008","journal-title":"Cell Cycle"},{"key":"R15-20260331","doi-asserted-by":"crossref","first-page":"25","DOI":"10.20517\/2394-4722.2023.34","article-title":"Role of epithelial-mesenchymal transition factor SNAI1 and its targets in ovarian cancer aggressiveness","volume":"9","author":"Suzuki","year":"2023","journal-title":"J Cancer Metastasis Treat"},{"key":"R16-20260331","doi-asserted-by":"crossref","first-page":"a029330","DOI":"10.1101\/cshperspect.a029330","article-title":"Loss of E-cadherin-dependent cell-cell adhesion and the development and progression of cancer","volume":"10","author":"Bruner","year":"2018","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"R17-20260331","doi-asserted-by":"crossref","first-page":"869069","DOI":"10.3389\/fcell.2022.869069","article-title":"Impact of vimentin on regulation of cell signaling and matrix remodeling","volume":"10","author":"Ostrowska-Podhorodecka","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"R18-20260331","doi-asserted-by":"crossref","first-page":"15127","DOI":"10.3390\/ijms232315127","article-title":"Post-translational modification of ZEB family members in cancer progression","volume":"23","author":"Park","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R19-20260331","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1080\/15384101.2015.1006048","article-title":"ZEB1: At the crossroads of epithelial-mesenchymal transition, metastasis and therapy resistance","volume":"14","author":"Zhang","year":"2015","journal-title":"Cell Cycle"},{"key":"R20-20260331","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1093\/carcin\/bgs161","article-title":"MicroRNA-regulated gene networks during mammary cell differentiation are associated with breast cancer","volume":"33","author":"Aydo\u011fdu","year":"2012","journal-title":"Molec Carcinog"},{"key":"R21-20260331","first-page":"2309","article-title":"The role of miR-200b\/c in balancing EMT and proliferation revealed by an activity reporter","volume":"40","author":"Gollavilli","year":"2021","journal-title":"Crit Rev Oncog"},{"key":"R22-20260331","doi-asserted-by":"crossref","first-page":"154597","DOI":"10.1016\/j.phymed.2022.154597","article-title":"Magnolol regulates miR-200c-3p to inhibit epithelial\u2013mesenchymal transition and retinoblastoma progression by modulating the ZEB1\/E-cadherin axis in vitro and in vivo","volume":"110","author":"Yu-Hung","year":"2023","journal-title":"Phytomedicine"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_356_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:45:26Z","timestamp":1787838326000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_356_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_356_25","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"2025-02-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-11","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}